— Know what they know.
Not Investment Advice
Also trades as: VIRP.PA (PAR) · $vol 2M

VRBCF OTC

Virbac S.A.
1W: +0.0% 1M: +0.0% 3M: -5.7% YTD: +10.8% 1Y: +10.8% 3Y: -3.4% 5Y: +14.1%
$383.25
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 37 · $3.2B mcap · 4M float · 0.0000% daily turnover · Short 73% of daily vol

Cash Flow Trends

Operating Cash Flow
$196M -4.2% ▼
5Y CAGR: +10.5%
Capital Expenditures
$92M -14.6% ▼
5Y CAGR: +24.4%
Free Cash Flow
$103M -16.5% ▼
5Y CAGR: +2.8%
Dividends Paid
$12M -9.9% ▼
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$9M +65.7% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$116M$121M$121M$146M$151M
Depreciation & Amort.$43M$46M$48M$57M$60M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$30M-$55M-$39M-$29M$14M
Other Non-Cash Items$10M-$8M-$10M$30M-$25M
Operating Cash Flow$130M$99M$119M$204M$196M
— Investing Activities —
Capital Expenditures-$47M-$54M-$41M-$69M-$102M
Acquisitions (Net)-$6M-$102K-$62M-$348M-$96M
Investment Purchases-$3M-$1M$0$0-$1M
Investment Sales$17M$1M$0$0$0
Other Investing-$12M-$1M-$18M-$11M$998
Investing Cash Flow-$51M-$55M-$122M-$429M-$199M
— Financing Activities —
Net Debt Issuance-$22M-$22M$38M$184M$19M
Stock Repurchased$0-$3M-$19M$0$0
Dividends Paid-$6M-$11M-$11M-$11M-$12M
Other Financing-$64M$1M-$10M-$35M-$13M
Financing Cash Flow-$92M-$35M-$3M$139M-$6M
Net Change in Cash-$7M$5M-$3M-$27M-$9M
Cash End of Period$172M$177M$173M$146M$122M
Free Cash Flow$83M$45M$78M$124M$103M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms